A bipartite mechanism for condensin II activation in mitosis

This study reveals that condensin II activation during mitosis operates via a bipartite mechanism where the protein M18BP1 both relieves autoinhibition by the NCAPD3 tail and directly enhances DNA anchoring through a positively charged loop, thereby enabling stable chromosome organization.

The Gist

The Big Picture: Packing the Suitcase for a Trip

Imagine your cell is a person getting ready for a very important trip (cell division). Inside this person's suitcase (the nucleus) are long, tangled strings of yarn (DNA). If you try to pull these strings apart while they are knotted and messy, the suitcase will rip, and the trip will fail.

To solve this, the cell needs to neatly fold the yarn into tight, organized bundles called chromosomes. The "folding machine" responsible for this is a protein complex called Condensin II.

However, there's a problem: Condensin II is always sitting inside the suitcase (the nucleus), even when the cell isn't dividing. If it started folding the yarn too early, it would cause chaos. So, the cell has a strict "safety lock" to keep the machine turned OFF until the exact moment it's needed.

This paper discovers exactly how that safety lock works and how the machine gets turned ON.

---

1. The Safety Lock: The "Tail" that Holds the Machine Down

Think of Condensin II as a high-tech robotic arm designed to grab yarn and loop it. But in its resting state, the robot is broken.

• The Problem: The robot has a long, floppy tail (called the NCAPD3Tail) that is wrapped tightly around its own grabbing claw (the NCAPH2Neck).
• The Result: Because the tail is holding the claw down, the robot cannot grab the yarn. It is "auto-inhibited." It's like a person wearing a seatbelt that is buckled so tightly they can't reach the steering wheel.

The researchers found that this tail acts as a self-imposed brake. As long as the tail is attached, the machine stays dormant, even if it has energy (ATP) to work.

2. The Key to the Lock: The "Activator" and the "Foreman"

So, how does the cell know when to start folding? It needs two things:

1. The Key: A protein called M18BP1.
2. The Foreman: A chemical signal from a protein called CDK1 (which acts like a foreman shouting, "It's time to work!").

Here is the step-by-step process of activation:

• Step A: The Foreman gives the order. The foreman (CDK1) puts a special "badge" (a phosphate group) on the Key (M18BP1). This badge makes the Key sticky and powerful.
• Step B: The Key arrives. The sticky Key (M18BP1) rushes to the Condensin II machine.
• Step C: The Tug-of-War. The Key tries to sit in the same spot where the robot's tail (NCAPD3Tail) is currently sitting. Because the Key is now super-sticky (thanks to the badge), it wins the tug-of-war.
• Step D: The Release. The Key kicks the tail off. Suddenly, the robot's claw (NCAPH2Neck) is free! The safety lock is broken, and the machine is ready to grab DNA.

3. The Surprise: The Key Does Double Duty

The researchers thought the Key (M18BP1) would just be a simple switch to turn the machine on. But they discovered something amazing: The Key also helps hold the yarn.

• The "Safety Belt" Analogy: Once the machine grabs the yarn and starts looping it, the yarn can sometimes slip out, like a loose knot.
• The Solution: The Key (M18BP1) has a long, positively charged "tail" of its own. When it attaches to the machine, this tail acts like a safety belt or a magnetic clamp. It wraps around the yarn and the machine, holding everything tight together.

Without this extra help, the machine would start folding the yarn, but the loops would be wobbly and fall apart. With the Key attached, the loops are strong and stable.

4. The "Bipartite" Mechanism: Two Jobs, One Protein

The paper calls this a "bipartite mechanism" (meaning "two-part"). This is the big discovery:

1. Part 1 (The Switch): M18BP1 kicks off the self-imposed tail to turn the machine ON.
2. Part 2 (The Stabilizer): M18BP1 stays attached to act as a magnetic anchor to keep the loops from falling apart.

Why Does This Matter?

If this system fails, the cell division goes wrong.

• If the machine turns on too early (like if the tail is missing), the chromosomes get tangled and damaged. This can lead to diseases like microcephaly (small brain size) or cancer.
• If the machine never turns on, the cell can't divide, and the organism can't grow.

Summary in One Sentence

The cell keeps its DNA-folding machine locked down by a self-wrapped tail, but when it's time to divide, a "Key" protein (boosted by a foreman) kicks the tail off to start the machine and then stays attached to act as a safety belt, ensuring the DNA is folded perfectly and securely.

Technical Summary

1. Problem Statement

Human condensin II is a constitutively nuclear molecular motor essential for organizing chromosomes into discrete sister chromatids during mitosis. While it is known to be active in mitosis and inactive during interphase, the precise molecular mechanism governing this temporal restriction has remained unclear.

• The Gap: Condensin II is an active ATPase capable of DNA binding, yet it does not globally compact chromatin during interphase. Previous hypotheses suggested inhibition by the protein MCPH1, intrinsic autoinhibitory elements within HAWK subunits, or phosphorylation events, but a unified structural and mechanistic model for how the complex transitions from an autoinhibited state to an active, DNA-looping state was missing.
• The Question: How is condensin II specifically activated at mitotic entry, and what are the structural mechanisms that prevent premature activation during interphase?

2. Methodology

The authors employed a multidisciplinary approach combining structural biology, single-molecule biophysics, and cell biology:

• Cryo-Electron Microscopy (Cryo-EM): Determined high-resolution structures of condensin II in multiple states:
  • Apo state (no ATP/DNA).
  • ATP-bound state.
  • Activated state (bound to M18BP1 and phosphorylated by CDK1/Cyclin B).
  • DNA-bound state (using the transition state analog ADP.BeFx).
• Single-Molecule Imaging: Used fluorescence microscopy to visualize loop extrusion dynamics in real-time, measuring loop growth rates, stability, and photobleaching steps to determine oligomeric states (monomer vs. dimer).
• Cell Biology (DT40 Cells): Utilized an analogue-sensitive CDK1 system to arrest cells in G2/M. They performed rescue experiments expressing wild-type or mutant NCAPD3 (the subunit containing the autoinhibitory tail) in cells where endogenous NCAPD3 was depleted. They also used CRISPR/Cas9 to knock out regulators like MCPH1 and M18BP1.
• Biochemical Assays:
  • Mass Photometry: Measured binding affinities and stoichiometry of condensin II complexes.
  • ATPase Assays: Measured ATP turnover rates of various mutants.
  • Electrophoretic Mobility Shift Assays (EMSA): Tested DNA binding capabilities of subcomplexes (NCAPG2-NCAPH2) with and without M18BP1.
  • Phosphorylation Studies: Used CDK1/Cyclin B to phosphorylate condensin II and/or M18BP1 to assess the impact on activation.

3. Key Contributions and Results

A. Structural Basis of Autoinhibition

• Apo State: In the absence of ATP, condensin II exists in a monomer-dimer equilibrium. The dimer interface involves NCAPG2 and the C-terminus of SMC4.
• The Autoinhibitory Mechanism: The authors identified a specific autoinhibitory tail within the NCAPD3 subunit (NCAPD3Tail). In the ATP-bound state (which is monomeric), the NCAPD3Tail wraps around the NCAPH2Neck domain and the NCAPG2 subunit.
  • This "proteinaceous belt" sequesters the NCAPH2Neck, preventing it from engaging with the SMC2 coiled-coils.
  • Consequently, the complex cannot form the closed DNA clamp required for capture, rendering it inactive.
• Validation: Deleting the NCAPD3Tail (specifically residues 1458-1463 or the entire tail) in DT40 cells caused Premature Chromosome Condensation (PCC) during G2 arrest, proving that the tail is essential for keeping condensin II inactive in interphase.

B. The Bipartite Activation Mechanism by M18BP1

The study reveals that the activator protein M18BP1 (Mis18BP1) activates condensin II through a two-step, bipartite mechanism, heavily dependent on CDK1 phosphorylation:

1. Relief of Autoinhibition (Step 1):

   • CDK1 phosphorylation of M18BP1 significantly enhances its binding affinity to condensin II.
   • M18BP1 competes directly with the NCAPD3Tail for the same binding site on NCAPG2.
   • Upon binding, M18BP1 displaces the NCAPD3Tail, liberating the NCAPH2Neck. This allows the NCAPH2Neck to reposition and engage with the SMC2 coiled-coils, priming the complex for DNA capture.
   • Note: Phosphorylation of M18BP1 is the critical trigger; phosphorylation of condensin II alone is insufficient for full activation.

2. Augmentation of DNA Anchoring (Step 2):

   • Beyond releasing the brake, M18BP1 actively stabilizes DNA loops.
   • The N-terminal Myb domain of M18BP1 binds to NCAPG2, while a long, basic (positively charged) linker region connects to the C-terminal binding site.
   • This creates a composite DNA-binding anchor (NCAPG2-NCAPH2-M18BP1) that forms a positively charged loop.
   • Single-molecule assays showed that while wild-type condensin II extrudes loops that are unstable (frequent "slippage" on the anchor side), the presence of M18BP1 (especially when phosphorylated) drastically increases loop lifetime by securing the anchor side of the DNA.

C. The DNA-Clamped State

• Cryo-EM of the DNA-bound state (with ADP.BeFx) revealed a closed "clamp" where DNA is topologically enclosed.
• The clamp is formed by the ATP-engaged SMC2/4 heads, the repositioned NCAPH2Neck, and the NCAPD3 subunit sealing the top.
• In this state, the NCAPG2 subunit is displaced from the core, indicating that the HEAT heterodimerization is disrupted to allow clamp closure.

4. Significance

• Mechanistic Clarity: This paper provides the first complete structural and mechanistic description of how a eukaryotic SMC complex is regulated. It resolves the long-standing question of how condensin II is restricted to mitosis.
• Bipartite Regulation: The discovery that M18BP1 serves a dual role—both releasing autoinhibition and providing a structural DNA anchor—challenges the view of activators as simple "on/off" switches. It suggests a sophisticated mechanism where the activator is integral to the mechanical stability of the loop.
• Disease Relevance: Premature activation of condensin II is linked to microcephaly and other chromosomal pathologies. Understanding the NCAPD3Tail/M18BP1 regulatory axis offers potential insights into the molecular basis of these diseases.
• General Principle: The study highlights a general regulatory theme for SMC complexes where "HAWK-B" subunits (like NCAPG2) serve as hubs for recruiting regulators, and extrinsic factors (like M18BP1) can provide "safety belts" to stabilize genome organization, distinct from the intrinsic "safety belts" seen in yeast condensins.

In summary, the authors demonstrate that condensin II is held in check by an internal tail (NCAPD3Tail) that blocks DNA capture. Mitotic entry triggers CDK1-mediated phosphorylation of M18BP1, which displaces this tail and simultaneously constructs a new, stable DNA-anchoring interface, ensuring that chromosome condensation occurs only at the correct time and with high fidelity.